Hirotoshi Matsuura - Concepedia

Author

Hirotoshi Matsuura

Toray Industries, Inc. (Japan)

Also Known As

Hirotoshi MATSUURA, Hirotoshi Matsuura

Publications

641

Citations

H-Index

Concepts

All Affiliations

Toray Industries, Inc. (Japan)Toray (United States)

About

Hirotoshi Matsuura is an author at Toray Industries, Inc. (Japan) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	609
2	Biochemistry	5	5	386
3	Natural Sciences	3	3	172
4	Health Sciences	2	2	197
5	Chemical Biology	1	1	26

Hirotoshi Matsuura

Publications

622

Citations

H-Index

Page 1

	Year	Citations
Discovery of a Structurally Novel Opioid .KAPPA.-Agonist Derived from 4,5-Epoxymorphinan. Hiroshi Nagase, Jun Hayakawa, Kuniaki Kawamura, Chemical and Pharmaceutical Bulletin Molecular PharmacologyBiochemistryMedicineMechanism Of ActionReceptor (Biochemistry)	1998	187
The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species. Shintaro Nishio, Hirotoshi Matsuura, Noriko Kanai, The Japanese Journal of Pharmacology ImmunologyPharmacotherapyPlatelet AggregationExperimental PharmacologyMolecular Pharmacology	1988	99
Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist Takashi Endoh, Hirotoshi Matsuura, Atsushi Tajima, Life Sciences Molecular PharmacologyPain DisordersHealth SciencesPain MedicineMedicine	1999	98
Design, synthesis, and structure–activity relationship of novel opioid κ-agonists Koji Kawai, Jun Hayakawa, Toru Miyamoto, Bioorganic & Medicinal Chemistry Structure–activity RelationshipMolecular PharmacologyBiochemistryDrug DesignMedicine	2008	74
Rational Drug Design and Synthesis of a Highly Selective Nonpeptide .DELTA.-Opioid Agonist, (4aS,12aR)-4a-(3-Hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine (TAN-67). Hiroshi Nagase, Koji Kawai, Jun Hayakawa, Chemical and Pharmaceutical Bulletin Selective Non-peptide AgonistsPeptide SciencePharmacotherapyExperimental PharmacologyPharmaceutical Chemistry	1998	72
Design and synthesis of a metabolically stable and potent antitussive agent, a novel δ opioid receptor antagonist, TRK-851 Satoshi Sakami, Koji Kawai, Masayuki Maeda, Bioorganic & Medicinal Chemistry BiochemistryMedicineMechanism Of ActionPharmacological AgentNeuropharmacology	2008	27
Beraprost sodium improves survival rates in anti-glomerular basement membrane glomerulonephritis and 5/6 nephrectomized chronic kidney disease rats Shinichi Yamaguchi, Chifumi Inada, Mitsutaka Tamura, European Journal of Pharmacology Glomerular DiseaseGlomerulonephritisBeraprost SodiumRenal FunctionSurvival Rates	2013	26
Syntheses of Non-Peptidic Delta Opioid Agonists and Their Structure Activity Relationships. Hiroshi Nagase, Hisanori Wakita, Koji Kawai, The Japanese Journal of Pharmacology Molecular PharmacologyBiochemistryMedicineNatural SciencesMechanism Of Action	1994	26
The In Vitro and Ex Vivo Antiplatelet Effect of TRK-100, a Stable Prostacyclin Analog, in Several Species Shintaro Nishio, Hirotoshi Matsuura, Noriko Kanai, The Japanese Journal of Pharmacology	1988	13

Page 1